Exane Asset Management’s Idexx Laboratories IDXX Stock Holding History

Exane Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-829	Closed	-$130K	–	149
2017 Q4	$130K	Buy	+829	New	+$130K	0.04%	64

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Exane Asset Management's IDXX Position: Q1 2018 in Review

Exane Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2018, closing a stake of 829 shares — an estimated $130K sold.

Exane Asset Management first reported a position in IDXX in Q4 2017 and held it in 1 quarter. The position peaked at $130K in Q4 2017. 645 funds tracked by Wall St. Rank hold IDXX as of Q1 2018.

Exane Asset Management reported no remaining Idexx Laboratories position as of Q1 2018 after selling out during the quarter.
Exane Asset Management sold 829 Idexx Laboratories shares in Q1 2018, an estimated $130K.
Exane Asset Management first reported a position in Idexx Laboratories in Q4 2017 and held it in 1 quarter.
Exane Asset Management's Idexx Laboratories position peaked at $130K in Q4 2017.
645 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2018.

Based on Exane Asset Management's 13F filing for Q1 2018, filed 30 Apr 2018.